Energy Transfer LP today announced the pricing of its concurrent offerings of $1.0 billion aggregate principal amount of 5.250% senior notes due 2029, $1.25 billion aggregate principal amount of.
Rapport Therapeutics Announces Pricing of Initial Public Offering tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
07.06.2024 - BOSTON and SAN DIEGO, June 06, 2024 (GLOBE NEWSWIRE) - Rapport Therapeutics, Inc. (Nasdaq: RAPP), a clinical-stage biotechnology company focused on discovery and development of transformational small molecule medicines for patients suffering from .
Royalty Pharma Announces Pricing of $1 5 Billion of Senior Unsecured Notes wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.